USPSTF: Data Still Not Good Enough to Back Asymptomatic AFib Screening
Physician's Weekly,
There’s still not enough evidence to truly assess the pros and cons of general screening for atrial fibrillation (AFib)…
There’s still not enough evidence to truly assess the pros and cons of general screening for atrial fibrillation (AFib)…
We’ve read the fine print -- and consulted experts -- about Apple’s irregular heart rhythm technology so you don’t have to.
Age- and Sex-Associated Impacts of Body Mass Index on Stroke Type Risk: A 27-Year Prospective Cohort Study in..., , Age- and…
Age- and Sex-Associated Impacts of Body Mass Index on Stroke Type Risk: A 27-Year Prospective Cohort Study in..., , Age- and…